Company & Sponsor Intelligence

China Medical University Hospital

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials9
Recruiting3
Completed4
Countries1

Therapeutic footprint

adhdautismdementia_otherdepressionparkinsons

Indexed studies

NCT04470037Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder
parkinsons · TaiwanPHASE2
NCT03072823Omega-3 Polyunsaturated Fatty Acids on Major Depressive Disorder in Patients With Cardiovascular Diseases
depression · TaiwanNA
NCT05512299Investigating Cerebellar Inhibition and Its Clinical Significance in Parkinsonian Tremor and Intention Tremor
parkinsons · TaiwanUNKNOWN
NCT02214251The Electrophysiological Investigation of Higher Level Neural Manifestations of Freezing of Gait in Parkinson's Disease Patient
parkinsons · TaiwanNA
NCT06811675The Efficacy of Dexamethasone in Combination With N-acetylcysteine in Preventing Neurocognitive Sequelae Due to Carbon Monoxide Poisoning
dementia_other · TaiwanPHASE4
NCT07365553Omega-3, Autism Spectrum Disorder (ASD)
autism · TaiwanNA
NCT03721887Exploit the Neural Source and the Feasibility of Transcranial Direct Current Stimulation for Freezing of Gait in Parkinson's Disease and Multiple System Atrophy
parkinsons · TaiwanNA
NCT06505460Exploring the Possible Beneficial Impact of Non-invasive and Invasive Neuromodulation on Freezing of Gait in Parkinson's Disease During Different Ambulatory Complexities: An Electrophysiological and fMRI Study
parkinsons · TaiwanNA
NCT03542643Omega-3 Polyunsaturated Fatty Acids in Youth With ADHD
adhd · TaiwanNA

Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →